Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitigating acute chemotherapy-associated adverse events in patients with cancer
Nicole M. Kuderer, Aakash Desai, Maryam B. Lustberg, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 11, pp. 681-697
Closed Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
Maryam B. Lustberg, Nicole M. Kuderer, Aakash Desai, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 527-542
Open Access | Times Cited: 104
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 71
Immunosurveillance in clinical cancer management
Guido Kroemer, Timothy A. Chan, Alexander M.M. Eggermont, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 74, Iss. 2, pp. 187-202
Open Access | Times Cited: 58
Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 20
The evolving landscape of tissue‐agnostic therapies in precision oncology
Vivek Subbiah, Mohamed A. Gouda, Bettina Ryll, et al.
CA A Cancer Journal for Clinicians (2024) Vol. 74, Iss. 5, pp. 433-452
Open Access | Times Cited: 19
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2– breast cancer
Aditya Bardia, Komal Jhaveri, Kevin Kalinsky, et al.
Future Oncology (2023) Vol. 20, Iss. 8, pp. 423-436
Open Access | Times Cited: 34
Peptide‐Based Supramolecular Therapeutics for Fighting Major Diseases
Zhongyan Wang, Hongjing Luo, Heping Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 25
Closed Access | Times Cited: 13
Intelligent gold nanocluster for effective treatment of malignant tumor via tumor-specific photothermal–chemodynamic therapy with AIE guidance
Feng Liu, Tianfeng Yang, Xiaowei Chang, et al.
National Science Review (2024) Vol. 11, Iss. 5
Open Access | Times Cited: 11
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01
Aditya Bardia, Komal Jhaveri, Seock‐Ah Im, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 10
Hyaluronic acid-functionalized graphene-based nanohybrids for targeted breast cancer chemo-photothermal therapy
Rita Lima‐Sousa, Bruna L. Melo, António Mendonça, et al.
International Journal of Pharmaceutics (2024) Vol. 651, pp. 123763-123763
Open Access | Times Cited: 9
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2089-2108
Closed Access | Times Cited: 9
Synergistic anticancer effect of Pistacia lentiscus essential oils and 5-Fluorouracil co-loaded onto biodegradable nanofibers against melanoma and breast cancer
Obaydah Abd Alkader Alabrahim, Hassan Mohamed El-Said Azzazy
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Adjuvant Properties of Caffeic Acid in Cancer Treatment
Nicole Cortez, Cecilia Villegas, Viviana Burgos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7631-7631
Open Access | Times Cited: 8
Urinary bioorthogonal reporters for the monitoring of the efficacy of chemotherapy for lung cancer and of associated kidney injury
Penghui Cheng, Ziling Zeng, Jing Liu, et al.
Nature Biomedical Engineering (2025)
Closed Access | Times Cited: 1
Deformable Smart DNA Nanomachine for Synergistic Intracellular Cancer‐Related miRNAs Imaging and Chemo‐Gene Therapy of Drug‐Resistant Tumors
Dong Chen, Ye‐Ran Wang, Zhilong Chen, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 7
Harnessing genetically engineered cell membrane-derived vesicles as biotherapeutics
Xiaohong Li, Yuting Wei, Zhirang Zhang, et al.
Extracellular Vesicles and Circulating Nucleic Acids (2024) Vol. 5, Iss. 1, pp. 44-63
Open Access | Times Cited: 6
Recent progress of porphyrin metal-organic frameworks for combined photodynamic therapy and hypoxia-activated chemotherapy
Qiuyun Zhang, Xiaohui Wang, Jiayi Chen, et al.
Chemical Communications (2024) Vol. 60, Iss. 93, pp. 13641-13652
Closed Access | Times Cited: 5
Glutathione-Responsive and Hydrogen Sulfide Self-Generating Nanocages Based on Self-Weaving Technology To Optimize Cancer Immunotherapy
Shuangquan Gou, Wenbo Geng, Yanan Zou, et al.
ACS Nano (2024) Vol. 18, Iss. 14, pp. 9871-9885
Closed Access | Times Cited: 4
Engineered oncolytic bacteria for malignant solid tumor treatment
Minjia Wang, Xuejiao Song, Xianglong Liu, et al.
Deleted Journal (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 4
Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved
Simona Serini, Gabriella Calviello
Antioxidants (2024) Vol. 13, Iss. 4, pp. 486-486
Open Access | Times Cited: 4
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1)
Hege O. Ohnstad, Egil Støre Blix, Lars A. Akslen, et al.
ESMO Open (2024) Vol. 9, Iss. 6, pp. 103475-103475
Open Access | Times Cited: 4
Dual‐Responsive Nanoreactor Initiates In Situ Generation of Copper Complex for Paraptosis‐Mediated Tumor Chemo‐Immunotherapy
Mei‐Ting Niu, Qian‐Ru Li, Qian‐Xiao Huang, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 4
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
Elena Catanzaro, Manuel Beltrán‐Visiedo, Lorenzo Galluzzi, et al.
Cellular and Molecular Immunology (2024)
Open Access | Times Cited: 4
Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting
Lu Sun, Jia Ma, Yajuan Zhou, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
The glowing frontier: Carbon dots' journey for customized cancer treatments
Anqi Liang, Jie Yang, Xiao Zhu, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106658-106658
Closed Access
Page 1 - Next Page

Scroll to top